Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Tannaz Razinia"'
Autor:
Jeffrey L. Saver, Tannaz Razinia, William G. Buxton, Bruce Ovbiagele, Norma McNair, Abdul Rahiman, Verna Porter
Publikováno v:
Journal of Stroke and Cerebrovascular Diseases. 17:5-8
Background Although various in-hospital stroke quality improvement programs have been associated with high treatment rates at hospital discharge, there are few data on the impact of these programs on clinical outcomes. We evaluated the impact of the
Autor:
Pablo Villablanca, Reza Jahan, Lucas Restrepo, F Vinuela, Tannaz Razinia, Oh Young Bang, Bruce Ovbiagele, Latisha K Ali, S. Starkman, Gary Duckwiler, Jeffery L Saver, Noriko Salamon, David S Liebeskind, Brian Buck
Publikováno v:
Neurology. 68:737-742
Background: Prestroke statin use may improve ischemic stroke outcomes, yet there is also evidence that statins and extremely low cholesterol levels may increase the risk of intracranial hemorrhage. We evaluated the independent effect of statin use an
Autor:
Pablo Villablanca, Jeffry R. Alger, David S Liebeskind, Nerses Sanossian, Jeffrey L. Saver, Tannaz Razinia, Doojin Kim, Noriko Salamon, Bruce Ovbiagele
Publikováno v:
Cerebrovascular Diseases. 22:378-383
Background: Cerebral microbleeds (CMB) detected on gradient-echo T2*-weighted MRI have been associated with cognitive impairment and the potential for increased risk of intracranial hemorrhage. We evaluated risk factors for these microangiopathic les
Autor:
Marta Rubiera, Izumi Oki, Pierre-Jean Touboul, David S Liebeskind, Askar Ghorbani, Toshisuke Sakaki, L. Korsholm, Rebecca F. Liberman, Noriko Salamon, Takao Urabe, J.P. Lejeune, Jacek Staszewski, Bogdan Brodacki, Hashem Shaltoni, Andrew P. Goldberg, Shigeru Fujimoto, S. Andrew Josephson, Claudia Chaves, Takehito Hayakawa, Jerzy Kotowicz, Aytekin Akyuz, Pablo Villablanca, Feng-Cheng Lin, Pranab Das, Abdolmehdi Baghaei, Kazunori Toyoda, Yasushi Okada, Adam Stępień, John D. Sorkin, Ching-Kuan Liu, E. Bernd Ringelstein, Monisha Dutta, Luigi Canciani, Sabri Batun, Ryota Tanaka, Kazimierz Tomczykiewicz, L. Thines, Tobias Poeplau, Steven R. Steinhubl, Chun-Hung Chen, Richard F. Macko, Christine M. Glastonbury, Carlos A. Molina, Hugues Chabriat, Shindokht Hosseini, Jennifer Pary, Patrizio Prati, Terubumi Watanabe, Frederick M. Ivey, James C. Grotta, Miki Komine-Kobayashi, Marzena Staszewska, Martin A. Ritter, Tomonori Okamura, X. Leclerc, Hirotsugu Ueshima, Juro Jinnouchi, Diego Vanuzzo, J.P. Mohr, Nancy K. Hills, Jun-ichi Iida, A. von Heijne, Norikiyo Nishikawa, Max Wintermark, Stephan P. Kloska, J.M. Wardlaw, Anne Schaefer, Marie-Germaine Bousser, Claire Gobron, C. Weimar, Giovanni Bader, Yoshikuni Kita, Bernadetta Moser, Letizia C.L. Antonietti, Mehmet Tatli, Shahram Oveisgharan, Akira Okayama, Lorenza Pilotto, Kinan Hreib, Grace M. Lee, Felix Adler, Shahin Shirani, Setsuro Ibayashi, José M. Ferro, Markku Kaste, Kenta Fujimoto, Jeffry R. Alger, Zsolt Garami, Nerses Sanossian, Hideaki Iwahashi, Yuan-Han Yang, Maurizio Ruscio, C. Taschner, John Y. Choi, Nizzal Sarrafzadegan, H. Mickley, Kazuo Yamashiro, Darius G. Nabavi, Rainer Dziewas, P. Bourgeois, Yoshikuni Mizuno, Shoichiro Kawaguchi, Marc D. Malkoff, Louis R. Caplan, Lucio Mos, Marco Casaroli, C. Lucas, Doojin Kim, K. Kraywinkel, Andrei V. Alexandrov, Lemuel A. Moyé, Gregory Allam, Seiji Gotoh, Elias Hanna, Brian M. Garrity, Alice S. Ryan, S. Claiborne Johnston, Hideaki Mishima, Charlene E. Hafer-Macko, Anand Viswanathan, F. Zairi, Aslan Guzel, Poyin Huang, Yosikazu Nakamura, Ruey-Tay Lin, J.K. Jensen, Yoko Yokoyama, M. Maschke, S. Bak, H.-C. Diener, Georg Röggla, Walter Heindel, Jeffrey L. Saver, Tannaz Razinia, S.R. Kristensen, Akbar Soltanzade, Bruce Ovbiagele
Publikováno v:
Cerebrovascular Diseases. 22:467-470
Autor:
Venkatakrishna Rajajee, Nerses Sanossian, Doojin Kim, Scott L Selco, Tannaz Razinia, Jeffery L Saver, Bruce Ovbiagele
Publikováno v:
Neurology. 66:319-323
To evaluate the independent effect of premorbid antiplatelet use on incident ischemic stroke severity and outcome at discharge.The authors studied consecutive patients presenting within 24 hours of ischemic stroke over a 1-year period. National Insti
Autor:
Jeffery L Saver, Venkatakrishna Rajajee, Bruce Ovbiagele, Chelsea S. Kidwell, Scott L Selco, Tannaz Razinia, Sidney Starkman
Publikováno v:
Neurology. 65:851-854
Background: Drugs that increase angiotensin 2 formation, including thiazides, calcium channel blockers, and angiotensin 2 type 1 (AT 1 ) receptor blockers, may be more effective in stroke prevention than angiotensin 2 suppressive drugs such as angiot
Autor:
Chelsea S. Kidwell, Bruce Ovbiagele, Scott L Selco, Jeffrey L. Saver, Tannaz Razinia, Venkatakrishna Rajajee, Andre Fredieu, Norma McNair, Shuichi Suzuki
Publikováno v:
Stroke. 35:2879-2883
Background and Purpose— The Stroke PROTECT (Preventing Recurrence Of Thromboembolic Events through Coordinated Treatment) program systematically implements, at the time of acute transient ischemic attack (TIA) or ischemic stroke admission, 8 medica
Autor:
Bruce Ovbiagele, Norma McNair, Andre Fredieu, Tannaz Razinia, Chelsea S. Kidwell, A. Dandekar, Jeffrey L. Saver, Shuichi Suzuki
Publikováno v:
Neurology. 63:1217-1222
Objective: To assess the impact of the Preventing Recurrence of Thromboembolic Events through Coordinated Treatment (PROTECT) Program on achievement of its eight secondary prevention goals at the time of discharge. Methods: Achievement rates for the
Publikováno v:
Cerebrovascular Diseases. 20:280-282
Publikováno v:
Evidence-Based Practice. 19:13